Clinical Applications for Targeted Therapy in Bladder Cancer

作者: Liana Adam , Wassim Kassouf , Colin P.N. Dinney

DOI: 10.1016/J.UCL.2005.02.004

关键词: GenomicsTransitional cell carcinomaBladder cancerMedicinePathologyProteomic ProfilingCancerProteomicsComputational biologyTargeted therapyStromal cell

摘要: The tremendous amount of data accumulated through genomics, proteomics, and meta-bolomic technologies has not led to a definitive understanding the mechanisms underlying cancer. challenge remains as how integrate all relevant knowledge in systematic manner so that researchers can gain needed devise best therapeutic diagnostic strategies. Human transitional cell carcinoma bladder is genetically heterogeneous, it surrounded by complex tissue microenvironment involving vasculature, stromal cells, connective tissue. One most challenging problems facing cancer lack correlation between vitro lines animal tumor models human vivo tumors. A few promising approaches are being devised will help address this issue coming years. such approach measurements molecular levels receptors, ligands, pathways components, on, directly tumors imaging, or proteomic profiling, been proposed standard protocol for diagnostics therapeutics.

参考文章(82)
Cora N. Sternberg, Alan Yagoda, Howard I. Scher, Robin C. Watson, Harry W. Herr, Michael J. Morse, Pramod C. Sogani, E. Darracott Vaughan, Neil Bander, Lora R. Weiselberg, Nancy Geller, Phyllis S. Hollander, Roberta Lipperman, William R. Fair, Willet F. Whitmore, M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for advanced transitional cell carcinoma of the urothelium. The Journal of Urology. ,vol. 139, pp. 461- 469 ,(1988) , 10.1016/S0022-5347(17)42494-3
Burt G. Feuerstein, Frederic M. Waldman, Richard L. Davis, Guido Sauter, Tatsuhiro Maeda, Patterns of epidermal growth factor receptor amplification in malignant gliomas. American Journal of Pathology. ,vol. 148, pp. 1047- 1053 ,(1996)
N.-H. Chow, Hsiao-Sheng Liu, Hsiao-Bai Yang, Shih-Huang Chan, Ih-Jen Su, Expression patterns of erbB receptor family in normal urothelium and transitional cell carcinoma. An immunohistochemical study. Virchows Archiv. ,vol. 430, pp. 461- 466 ,(1997) , 10.1007/S004280050056
N Longo, R.C. Shuster, L.D. Griffin, S.D. Langley, L.J. Elsas, Activation of insulin receptor signaling by a single amino acid substitution in the transmembrane domain. Journal of Biological Chemistry. ,vol. 267, pp. 12416- 12419 ,(1992) , 10.1016/S0021-9258(18)42290-9
Keith A Baggerly, Li Deng, Jeffrey S Morris, C Marcelo Aldaz, Overdispersed logistic regression for SAGE: Modelling multiple groups and covariates BMC Bioinformatics. ,vol. 5, pp. 144- 144 ,(2004) , 10.1186/1471-2105-5-144
Michael David, Lily Wong, Richard Flavell, Stewart A. Thompson, Alan Wells, Andrew C. Larner, Gibbes R. Johnson, STAT Activation by Epidermal Growth Factor (EGF) and Amphiregulin REQUIREMENT FOR THE EGF RECEPTOR KINASE BUT NOT FOR TYROSINE PHOSPHORYLATION SITES OR JAK1 Journal of Biological Chemistry. ,vol. 271, pp. 9185- 9188 ,(1996) , 10.1074/JBC.271.16.9185
Tzong-Shin Tzai, Chung-Liang Ho, Hsiao-Sheng Liu, Shih-Huang Chan, Nan-Haw Chow, Expression Profiles of ErbB Family Receptors and Prognosis in Primary Transitional Cell Carcinoma of the Urinary Bladder Clinical Cancer Research. ,vol. 7, pp. 1957- 1962 ,(2001)
Nancy E Hynes, Tyrosine kinase signalling in breast cancer Breast Cancer Research. ,vol. 2, pp. 154- 157 ,(2000) , 10.1186/BCR48